Drug intelligence / Profile preview

ProteiOS

Development stage
Unknown
Lead developer
ISTO Biologics
Modality
Recombinant Proteins and Enzymes, Peptides
Administration
Implant
01

Overview

ProteiOS is an allograft-derived orthobiologic developed by ISTO Biologics, designed to facilitate bone formation and remodeling in spinal fusion and other orthopedic procedures. It consists of a naturally derived concentrate of nearly 1,000 unique proteins, growth factors, and peptides, including bone morphogenetic protein-2 (BMP-2), platelet-derived growth factor (PDGF), transforming growth factor-beta 1 (TGF-β1), and vascular endothelial growth factor (VEGF). The product is processed through proprietary methods to remove cellular and self-identifying antigens and is terminally sterilized via gamma irradiation. Clinical data suggests ProteiOS provides superior fusion rates compared to autograft and other advanced orthobiologics like rhBMP-2 (Infuse) and OsteoAMP.

Brand names
ProteiOS
Other names
ProteiOS
02

Targets

VEGFR (VEGFR family)PDGFR (PDGFR family)TGFBR (TGF-beta receptor)BMPR (Bone morphogenetic protein receptor)

Beyond the preview

Go deeper on ProteiOS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProteiOS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call